Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

175.15 -0.72 (-0.41%)
Streaming Delayed Price Updated: 10:01 AM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Webinar: Collaborating to Address Health Inequities in Underserved Communities
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics to Provide K-12 School COVID-19 Testing in Collaboration with Ginkgo Bioworks to Support Safer Classroom Learning in Texas for New Statewide School Testing Program
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Regulatory Compliance
Exposures COVID-19 Legal Regulatory
What 5 Analyst Ratings Have To Say About Quest Diagnostics
Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the follow... 
Via Benzinga
Our Commitment to a Diverse Workforce and Equitable Compensation
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Supply Chain
Exposures Supply Chain
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
DGX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Give it a Shot: The Latest on the Flu & COVID Vaccine
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics: Q3 Earnings Insights
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:45 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Supporting Employees' Emotional Health During the Pandemic
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3
Quest Diagnostics Incorporated (NYSE: DGX) has posted a better-than-expected Q3 adjusted EPS of $3.96, down 7.9% Y/Y, beating the consensus estimate of $2.87. Sales... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For October 21, 2021
Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •... 
Via Benzinga
Earnings Outlook For Quest Diagnostics
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2021-10-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Price Over Earnings Overview: Quest Diagnostics
Right now, Quest Diagnostics Inc. (NYSE:DGX) share price is at $145.77, after a 1.43% gain. Moreover, over the past month, the stock fell by 5.60%, but in the past... 
Via Benzinga
Communities of Color Hit Hardest by COVID-19 and Lack Trust in Healthcare
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.... 
Via Benzinga
Exposures Product Safety
DA Authorizes Quest Diagnostics' COVID-19 Collection Materials for Emergency Use
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19 Product Safety
Reducing Health Inequities While Expanding the Pipeline to Create a More Diverse Health Care Workforce
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Addressing the Healthcare Needs of Underserved Communities
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Overview Of Value Stocks In The Healthcare Sector
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
Over Half of U.S. Children Have Detectable Levels of Lead in Their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Energy
Exposures COVID-19 Fossil Fuels Lead
The Delta Variant Has Made Quest Diagnostics Indispensable
On the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year. 
Via The Motley Fool
Exposures COVID-19
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
Via FinancialNewsMedia
Exposures COVID-19
Engaging Student Journalists to Promote Health Awareness
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Black and Hispanic Communities Are Lagging in Getting Vaccinated. How These Organizations Are Trying to Change That
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Death
Exposures COVID-19 Death
Learn More About Quest’s Commitment to Patients, Clients, Employees and Communities by Reading the Company’s Annual Corporate Responsibility Report
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
Instead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology
These businesses have exposure to blockchain technology and they're safer options than buying crypto directly. 
Via The Motley Fool
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates
Via FinancialNewsMedia
Exposures COVID-19
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.